3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
19
Metastatic Castration-resistant Prostate Cancer
3
Prostatic Diseases
2
Urogenital Neoplasms
1
Renal Insufficiency
1
Prostate Cancer Metastatic
1
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
1
Neoplasms by Site
1
Neoplasms
1
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
1
Male Urogenital Diseases
1
Liver Neoplasms
1
Kidney Neoplasms
1
Glioma
1
Glioblastoma
1
Genital Neoplasms, Male
1
Genital Diseases, Male
1
Disease
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Hepatocellular
1
Astrocytoma
1
Interventions
Blood Specimen Collection
3
Observation
2
Magnetic Resonance Imaging
2
Biopsy
2
tislelizumab
1
pembrolizumab
1
fluorocholine
1
atezolizumab
1
abiraterone
1
Videotape Recording
1
TIC10 compound
1
Surveys and Questionnaires
1
Specimen Handling
1
Referral and Consultation
1
Prostatectomy
1
Preoperative Exercise
1
Prednisone
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Nephroureterectomy
1
Mass Screening
1
Mammography
1
Interleukin-15
1
High-Intensity Interval Training
1
Hematologic Tests
1
Food
1
Endosonography
1
Educational Status
1
Diagnostic Techniques and Procedures
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Disease
×
Pluvicto
×
Clear all
NCT07054346
2026-04-01
LUTACT
University of California, San Francisco
Phase 1
Recruiting
45 enrolled